张广厚

    【摘要】目的：研究对于慢性硬膜下血肿患者在进行钻孔引流术后采用联合药物(阿托伐他汀+地塞米松)治疗的效果情况。方法：回顾性分析2013年1月—2021年10月75例慢性硬膜下血肿患者的临床资料，分组依据是按照不同的治疗方法来分成了两组，研究组(n=40)钻孔引流术后采用阿托伐他汀联合地塞米松治疗，对照组(n=35)术后单用阿托伐他汀治疗。动态监测两组患者术后血肿残余量，评估神经功能评分，观察并发症及血肿复发情况。结果：两组术后血肿残余量均明显减少(P<0.05)，尤其是研究组减少的程度比对照组更大(P<0.05)。两组术后CSS评分均明显降低(P<0.05)，且研究组降低的程度比对照组更大(P<0.05)。两组出现并发症的情况分析没有显著性(P>0.05)，并且研究组血肿复发率比对照组明显的减少(P<0.05)。结论：对于慢性硬膜下血肿患者在进行钻孔引流术后采用联合药物(阿托伐他汀+地塞米松)治疗可有效促进血肿消退，促进神经功能更快恢复，并降低复发率。

    【关键词】阿托伐他汀；地塞米松；慢性硬膜下血肿；钻孔引流术

    Effect of Atorvastatin Combined with Dexamethasone on patients with chronic subdural hematoma after drilling and drainage

    ZHANG Guanghou

    The first people’s Hospital of Zhenyuan County， Qingyang， Gansu 744500， China

    【Abstract】Objective： To study the effect of combined drugs (atorvastatin + dexamethasone) on patients with chronic subdural hematoma after drilling and drainage. Methods： The clinical data of 75 patients with chronic subdural hematoma from January 2013 to October 2021 were analyzed retrospectively. The grouping is based on different treatment methods. The study group (n=40) was treated with atorvastatin combined with dexamethasone after drilling and drainage ......